Tranont Adds Metabolic Health Expert Dr. Erin Glynn to Advisory Board
In a bold move that underscores its continued investment in science-driven wellness and product development, Tranont, a company known for delivering high-quality dietary supplements and wellness solutions, has announced the addition of Dr. Erin Glynn to its Scientific Advisory Board. A distinguished figure in the fields of metabolic health, clinical nutrition, and dietary supplement formulation, Dr. Glynn brings with her more than 20 years of expertise spanning academia and the nutraceutical industry.
This appointment marks a significant step forward in Tranont’s commitment to scientific rigor, innovation, and targeted product development, especially in the rapidly growing field of women’s health. With a mission to improve 1 billion lives for good, Tranont continues to attract high-caliber talent and deepen its scientific leadership. Dr. Glynn’s arrival is expected to accelerate the company’s progress across product innovation, educational outreach, and evidence-based health solutions.
A Career Steeped in Science, Wellness, and Innovation
Dr. Glynn’s academic and professional background reads like a blueprint for excellence in health science. She began her journey with a Bachelor of Science in Exercise Physiology from Texas A&M University, where she developed a foundational understanding of human physiology and performance. Her passion for preventive health and population-level wellness then led her to pursue a Ph.D. in Preventive Medicine and Community Health at the University of Texas Medical Branch.
Seeking to bridge the gap between research and real-world impact, Dr. Glynn completed a prestigious postdoctoral fellowship at Duke University’s Stedman Nutrition and Metabolism Center, a research institute recognized globally for pioneering work in nutrition, energy balance, and metabolic function. During this time, she honed her expertise in advanced metabolic pathways, clinical trial design, and translational research—the very tools she now applies to dietary supplement development.
Over the course of her scientific career, Dr. Glynn has published more than 30 peer-reviewed research papers and delivered keynote presentations at leading scientific and medical conferences across the country. Her publications span a broad range of topics including metabolic syndrome, obesity interventions, nutritional biochemistry, and functional health outcomes. She has built a reputation not only as a thought leader in her field, but as a communicator who can translate complex scientific data into practical insights for consumers and health professionals alike.
Bringing Scientific Depth and Strategic Insight to Tranont
In her new role on Tranont’s Scientific Advisory Board, Dr. Glynn will provide strategic guidance and hands-on leadership in a number of critical areas. She will work closely with Tranont’s executive team and product developers to guide the scientific direction of upcoming innovations, support evidence-based product formulation, and ensure that Tranont’s offerings remain at the forefront of nutritional science.
One of her key responsibilities will be to oversee the scientific development and validation of products, ensuring they meet rigorous quality standards and deliver real, measurable benefits to consumers. This includes evaluating new ingredients, refining product formulations, and collaborating with other health experts to assess the latest clinical research.
Additionally, Dr. Glynn will play a central role in educational outreach, particularly by developing training materials and programs for Tranont’s field leaders and associates. With a unique talent for making science both accessible and actionable, she aims to empower Tranont’s salesforce with the knowledge and confidence needed to communicate product benefits effectively to customers.
“I am absolutely thrilled and honored to join the Tranont family as part of the Scientific Advisory Board,” said Dr. Glynn in a statement. “What truly drew me to Tranont was not only the company’s mission to create lasting impact at scale, but also its commitment to quality, innovation, and science-backed formulations. From game-changing products like DHS to targeted solutions such as Tranont For Her and the newly launched Creatine formula, it’s evident that this is a company passionate about making a difference in people’s lives.”
A Strategic Focus on Women’s Health
Dr. Glynn’s appointment is particularly timely given Tranont’s heightened focus on women’s health—a segment of the wellness market that has historically been underserved but is now gaining overdue attention. Her deep knowledge of female physiology, hormonal balance, and metabolic diversity across the lifespan positions her as a key figure in shaping Tranont’s efforts to create targeted solutions for women.
Tranont aims to deliver simple, science-backed, and lifestyle-compatible wellness products that support women in feeling and performing at their best. Dr. Glynn’s strategic input will influence product lines that address critical health concerns such as energy, cognitive performance, muscle health, immune resilience, and gut-brain axis function—all through the lens of female-specific needs.
“Dr. Glynn’s expertise in metabolism and gut health will be instrumental in guiding the next generation of Tranont’s health products,” said Russell Losee, Tranont’s Co-Founder and Chief Operating Officer. “Her track record in both academic research and product development speaks for itself. But even more importantly, her holistic, people-centered approach to health and wellness aligns perfectly with our core values. We are excited to collaborate with her in crafting innovative products and providing educational resources that help our associates succeed.”
Industry Experience Rooted in Real-World Impact
Beyond academia, Dr. Glynn has spent the past decade working in the private sector, where she led research and development teams at major health and wellness companies. In these roles, she was responsible for designing and launching clinically validated supplements, many of which went on to become market leaders in their categories. She has built and managed multi-disciplinary teams, coordinated clinical trials, and worked with formulators, nutritionists, and regulatory experts to deliver products that meet the highest standards of efficacy and safety.
Her dual lens of scientific rigor and commercial practicality allows her to translate cutting-edge research into scalable health solutions. Moreover, her experience navigating industry trends and consumer behaviors provides valuable insight into where the supplement market is headed—and how Tranont can stay ahead.
Dr. Glynn is known within the industry not only for her scientific acumen, but also for her passion for education, mentorship, and empowering others. She has led numerous workshops and webinars on metabolic health, ingredient science, and nutritional coaching, and continues to advocate for more inclusive and diverse representation in health research and product design, particularly for women.
Transforming Health Through Science and Empowerment
With Dr. Glynn’s appointment, Tranont is doubling down on its promise to deliver transformative health solutions rooted in science, backed by real data, and designed to meet the evolving needs of modern consumers. Her leadership will help shape not only the next generation of products, but also the way Tranont’s community engages with health information and shares wellness journeys.
As Tranont continues its mission to impact 1 billion lives for good, the company recognizes that empowering people begins with knowledge and trust. By building a team of scientific leaders like Dr. Glynn, Tranont is ensuring that its future is as innovative, inclusive, and evidence-based as its ambition demands.
In a time when consumers are increasingly looking for transparency, credibility, and results in their wellness products, Dr. Erin Glynn’s voice and vision are poised to become a defining force within Tranont—and a catalyst for meaningful health transformation around the world.
